Literature DB >> 21366428

Clinical presentation and outcome of retinoblastoma among children treated at the National Cancer Institute (NCI) in Gezira, Sudan: a single Institution experience.

Amel A E Ali1, Sara M A Elsheikh, Ahmed Elhaj, Nada Osman, Dafalla Abuidris, Elgylani A Eltayeb, Maha Mahgoub, Anas Hamdoun, Mohamed Mousa Babiker, Ahmed A Mohamedani, Nasr Eldin M A Elwali, Ibrahim Qaddoumi.   

Abstract

BACKGROUND: Retinoblastoma (RB) is a rare and unique cancer that affects the eyes of very young children. There are few reports on RB in Sudan.
MATERIALS AND METHODS: We performed a retrospective study of data from patients diagnosed with retinoblastoma between January 1999 and December 2009 at the National Cancer Institute in Gezira (NCI-Gezira).
RESULTS: Of the 519 cases of childhood cancer treated at NCI-Gezira during the study period, 25 (4.8%) were retinoblastoma. Of these 25 patients with retinoblastoma, there were 13 boys and 19 cases were unilateral. The median age at diagnosis was 36 months (range, 8-60 months). The disease was localized in 9 patients, regional in 5 patients, and metastatic in 11 patients. The most frequent symptoms were enlarged eye (n = 14) and leukocoria (n = 8). Nine patients (36%) have been lost to follow-up; 9 were alive at last follow-up (7 in remission, 2 progressed); and 7 have died (5 from disease and 2 from unrelated causes). Twenty-two eyes were enucleated in 16 patients (6 bilateral and 10 unilateral). Pathologic examination of the enucleated eyes could only be completed in 11 patients. Diagnostic imaging in the form of computerized tomography scans or ultrasonography of the brain and orbit was done for 10 patients (40%).
CONCLUSIONS: Although these findings are not surprising, and similar to reports from other developing countries, we hope our work will provide a foundation for strategies to improve outcome for retinoblastoma in our center such as proper training, public awareness, team approach, and twinning.

Entities:  

Mesh:

Year:  2011        PMID: 21366428     DOI: 10.3109/13816810.2010.546822

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  13 in total

Review 1.  Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.

Authors:  C L Shields; E M Fulco; J D Arias; C Alarcon; M Pellegrini; P Rishi; S Kaliki; C G Bianciotto; J A Shields
Journal:  Eye (Lond)       Date:  2012-09-21       Impact factor: 3.775

2.  Clinical Presentations and Outcomes of Retinoblastoma Patients in relation to the Advent of New Multimodal Treatments: A 12-Year Report from Single Tertiary Referral Institute in Thailand.

Authors:  Duangnate Rojanaporn; Taweevat Attaseth; Wimwipa Dieosuthichat; Kitikul Leelawongs; Samart Pakakasama; Usanarat Anurathapan; Ekachat Chanthanaphak; Sirintara Singhara Na Ayudhaya; Rangsima Aroonroch; Suradej Hongeng
Journal:  J Ophthalmol       Date:  2020-09-10       Impact factor: 1.909

3.  Retinoblastoma major review with updates on Middle East management protocols.

Authors:  Ihab Saad Othman
Journal:  Saudi J Ophthalmol       Date:  2012-04

4.  Retinoblastoma in the democratic republic of congo: 20-year review from a tertiary hospital in kinshasa.

Authors:  Aimé Kazadi Lukusa; Michel Ntetani Aloni; Bertin Kadima-Tshimanga; Moïse Mvitu-Muaka; Jean Lambert Gini Ehungu; René Ngiyulu; Pépé Ekulu Mfutu; Aléine Budiongo Nzazi
Journal:  J Cancer Epidemiol       Date:  2012-04-26

5.  Management of retinoblastoma with extraocular tumour extension.

Authors:  Swathi Kaliki; Vijay Anand Reddy Palkonda
Journal:  Community Eye Health       Date:  2018

6.  Retinoblastoma: A retrospective analysis of 141 patients from 1983 to 2013 at a tertiary care hospital in Nagpur, India.

Authors:  Rohit S Kabre; Krishna M Kamble
Journal:  South Asian J Cancer       Date:  2019 Jul-Sep

7.  Retinoblastoma Presentation and Survival: A four-year analysis from a tertiary care hospital.

Authors:  Nida Zia; Ahmer Hamid; Sundus Iftikhar; Muhammad Hamza Qadri; Anzal Jangda; Muhammad Rahil Khan
Journal:  Pak J Med Sci       Date:  2020-01       Impact factor: 1.088

8.  Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes.

Authors:  Meaghann S Weaver; Christina L Heminger; Catherine G Lam
Journal:  BMC Public Health       Date:  2014-09-11       Impact factor: 3.295

9.  Retinoblastoma in a pediatric oncology reference center in Southern Brazil.

Authors:  Simone G A Selistre; Marcelo K Maestri; Patricia Santos-Silva; Lavinia Schüler-Faccini; Luis S P Guimarães; Juliana Giacomazzi; Mario C Evangelista Júnior; Patricia Ashton-Prolla
Journal:  BMC Pediatr       Date:  2016-04-03       Impact factor: 2.125

10.  Retinoblastoma in Sub-Saharan Africa: Case Studies of the Republic of Côte d'Ivoire and the Democratic Republic of the Congo.

Authors:  Robert M Lukamba; Jean-Jacques A Yao; Theophile A Kabesha; Aleine N Budiongo; Ben B Monga; Albert T Mwembo; Pierre Bey; Gabrielle B Chenge; Laurence Desjardins; Oscar N Luboya; François Doz; Cristina D Stefan
Journal:  J Glob Oncol       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.